Nanolyze
Nanolyze develops patented waveguide-based instruments for the label-free, real-time analysis of nanoparticles at single-particle resolution. The technology enables researchers to investigate how viruses, exosomes, and drug delivery vehicles interact with proteins and biomolecules in various biological fluids. The company primarily serves the nanomedicine and nanoscience research sectors to assist in the development of diagnostic applications and therapies.
Visit websiteMölndal, Sweden
Deeptech
Nanotechnology
Biotechnology
Life Sciences
Funding summary
- Total raised
- €1.1M
- Funding rounds
- 1
Investors in Nanolyze
Investors on record for Nanolyze. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Nanolyze?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors